Sartorius T-Cell Allogeneic Manufacturing Solution
Functionally closed, scalable solution to produce consistent, high-quality allogeneic CAR-T cells
Control strategy: Monitor processes and enact manufacturing control strategy through advanced, sensitive control, consistent serum-free, xeno-free T-cell medium, single-use fluidized bed counter-flow centrifugation platform, and 3-hour PCR-based sterility checkpoints
Automation: Streamline CAR-T production with integrated DCU for real-time monitoring of cell growth throughout expansion with substrate addition via multiple controllers
Remote manufacturing: Gain real-time process insight for possible manufacturing trajectory correction with Sartorius multivariate prediction technology
Assured supply: Maintain consistently high CAR-T cell product quality with low-E&L consumables manufactured under complete control of single-use supply chain and with long-term business continuity
Control Strategy
Biostat® RM
Automated, fully GMP-compliant, wave-mixed bioreactor for CAR-T cell expansion with fed-batch, perfusion or a combination
4Cell® Nutri-T
Xeno-free, serum-free medium specifically designed for the culture and expansion of lymphocytes
Automation
Biostat® RM
Automated, fully GMP-compliant, wave-mixed bioreactor for CAR-T cell expansion with fed-batch, perfusion or a combination